Abiraterone Acetate

From WikiMD.org
Jump to navigation Jump to search
Abiraterone Acetate
TermAbiraterone Acetate
Short definitionAbiraterone Acetate (A-bih-RA-teh-rone A-seh-tayt) medicine used with other medicines to treat prostate cancer that has spread to other parts of the body. Abiraterone acetate is used under the brand name Zytiga to treat patients whose cancer is castration-resistant (has not responded to treatments to lower testosterone levels) or whose cancer is at high risk and castration-sensitive (has responded to treatments to lower testosterone levels). 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Abiraterone Acetate - (pronounced) (A-bih-RA-teh-rone A-seh-tayt) medicine used with other medicines to treat prostate cancer that has spread to other parts of the body. Abiraterone acetate is used under the brand name Zytiga to treat patients whose cancer is castration-resistant (has not responded to treatments to lower testosterone levels) or whose cancer is at high risk and castration-sensitive (has responded to treatments to lower testosterone levels). It is also used under the brand name Yonsa to treat patients whose cancer is resistant to castration. Abiraterone acetate is also being studied to treat other types of cancer. It lowers the amount of androgens (male hormones) like testosterone produced by the body. This can stop the growth of cancer cells that need androgens to grow. Abiraterone acetate is a type of antiandrogen

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski